Merck Sharp & Dohme v. Mylan Pharmaceuticals ( 2013 )

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ MERCK SHARP & DOHME CORP., MSD INTERNATIONAL GMBH, Plaintiffs-Appellees, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant. ______________________ 2012-1434 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 10-CV-3085, Judge Jose L. Linares. ______________________ JUDGMENT ______________________ DAVID T. PRITIKIN, Sidley Austin, LLP, of Chicago, Illinois, argued for plaintiffs-appellees. With him on the brief were WILLIAM H. BAUMGARTNER, JR. and CONSTANTINE L. TRELA, JR.; and PETER S. CHOI, of Wash- ington, DC; and TODD L. KRAUSE, of New York, New York. Of counsel on the brief were PAUL D. MATUKAITIS, EDWARD W. MURRAY and LISA A. JAKOB, Merck & Co., Inc., of Rahway, New Jersey. Of counsel was DONALD A. ROBINSON, Robinson, Wettre & Miller LLC, of Newark, New Jersey. THOMAS J. PARKER, Alston & Bird, LLP, of New York, New York, argued for defendant-appellant. Of counsel were BLAS P. ARROYO and JITENDRA MALIK, of Charlotte, North Carolina; and DEEPRO MUKERJEE, of New York, New York. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (DYK, MAYER, and REYNA, Circuit Judg- es). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT February 7, 2013 /s/ Jan Horbaly Date Jan Horbaly Clerk